united states district court northern district of...

63
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF GEORGIA Julie Williams and Randall Williams, individually and as Parents and Natural Guardians of M.C.W., a Minor, Plaintiffs, v. GLAXOSMITHKLINE LLC Defendants. ) ) ) ) ) ) ) ) ) ) ) ) Civil No. JURY TRIAL DEMANDED NOTICE OF REMOVAL Defendant GlaxoSmithKline LLC (“GSK”), removes the state court action entitled Julie Williams, et al. v. GlaxoSmithKline LLC, No. 16A-02416-5, from the Superior Court of Gwinnett County, Georgia, to the United States District Court for the Northern District of Georgia, Atlanta Division, pursuant to 28 U.S.C. §§ 1332, 1441, and 1446. 1 In support of the removal, GSK respectfully states as follows: 1. This is a pharmaceutical product liability case. On or about March 14, 2016, Plaintiffs Julie Williams and Randall Williams commenced this action by serving a summons and complaint (“Complaint”) on GSK. A true and correct copy 1 By removing this action to this Court, GSK does not waive any defenses, objections, or motions available under state or federal law. GSK expressly reserves the right to move for dismissal of some or all of Plaintiffs’ claims and/or seek dismissal based on lack of personal jurisdiction, improper venue, and/or the doctrine of forum non conveniens. Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 1 of 9

Upload: others

Post on 26-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF GEORGIA

Julie Williams and Randall Williams, individually and as Parents and Natural Guardians of M.C.W., a Minor, Plaintiffs, v. GLAXOSMITHKLINE LLC Defendants.

) ) ) ) ) ) ) ) ) ) ) )

Civil No. JURY TRIAL DEMANDED

NOTICE OF REMOVAL

Defendant GlaxoSmithKline LLC (“GSK”), removes the state court action

entitled Julie Williams, et al. v. GlaxoSmithKline LLC, No. 16A-02416-5, from the

Superior Court of Gwinnett County, Georgia, to the United States District Court

for the Northern District of Georgia, Atlanta Division, pursuant to 28 U.S.C. §§

1332, 1441, and 1446.1 In support of the removal, GSK respectfully states as

follows:

1. This is a pharmaceutical product liability case. On or about March 14,

2016, Plaintiffs Julie Williams and Randall Williams commenced this action by

serving a summons and complaint (“Complaint”) on GSK. A true and correct copy

1By removing this action to this Court, GSK does not waive any defenses, objections, or motions available under state or federal law. GSK expressly reserves the right to move for dismissal of some or all of Plaintiffs’ claims and/or seek dismissal based on lack of personal jurisdiction, improper venue, and/or the doctrine of forum non conveniens.

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 1 of 9

Page 2: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

2

of the summons and Complaint are attached to this Notice of Removal as Exhibit

A. Plaintiffs assert claims for injuries and damages allegedly experienced by

M.C.W. as a result of her mother’s use of Zofran®, an FDA-approved prescription

medicine manufactured by GSK. Plaintiffs bring claims against GSK for

negligence, negligence per se, fraudulent misrepresentation, fraudulent

concealment, and negligent misrepresentation. (Compl. ¶¶ 105-170).

2. As explained below, this Court has original subject matter jurisdiction

over this civil action pursuant to 28 U.S.C. § 1332, and the action may be removed

to this Court under 28 U.S.C. § 1441 because (i) there is complete diversity of

citizenship between Plaintiffs and Defendant, and (ii) the amount in controversy

exceeds the sum or value of $75,000, exclusive of interest and costs.

DIVERSITY OF CITIZENSHIP

3. GSK is, and was at the commencement of this action, a citizen of the

State of Delaware for purposes of diversity jurisdiction.

4. GSK is a limited liability company. The sole member of GSK is, and

was at the commencement of this action, GlaxoSmithKline Holdings (Americas)

Inc. (“GSK Holdings”). Because Delaware is both GSK Holdings’ state of

incorporation and the location of its principal place of business, GSK Holdings is

solely a citizen of Delaware. Therefore, GSK also is solely a Delaware citizen.

5. For purposes of diversity jurisdiction, determining the citizenship of

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 2 of 9

Page 3: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

3

GSK is a two-step process. First, under the Eleventh Circuit’s ruling in Rolling

Greens MHP, L.P. v. Comcast SCH Holdings L.L.C., 374 F.3d 1020, 1022 (11th

Cir. 2004), a limited liability company is a citizen of any state of which a member

of the company is a citizen. Second, under the Supreme Court’s ruling in Hertz

Corp. v. Friend, 130 S. Ct. 1181, 1185-86 (2010), a corporation is a citizen of the

state in which it is incorporated and the state in which it has its principal place of

business, as determined by the “nerve center” test.

6. Based on this two-step analysis, GSK is solely a citizen of Delaware.

First, under Rolling Greens, GSK’s citizenship is defined solely by the citizenship

of its only member, GSK Holdings. Second, under Hertz, GSK Holdings is solely

a citizen of Delaware, because it was incorporated under the laws of Delaware and

has its principal place of business in Delaware. The sole member of GSK is GSK

Holdings. Because Delaware is both GSK Holdings’ state of incorporation and the

location of its nerve center, GSK Holdings is solely a citizen of Delaware.

Therefore, GSK also is solely a Delaware citizen. See Johnson v. SmithKline

Beecham Corp., 724 F.3d 337, 356-57, 360 (3d Cir. 2013).

7. Plaintiffs are now, and were at the commencement of this action,

citizens of the State of Georgia. (Compl. ¶¶ 20-22).

8. Accordingly, there exists complete diversity among the parties

because Plaintiffs are citizens of Georgia and GSK is a citizen of Delaware.

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 3 of 9

Page 4: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

4

AMOUNT IN CONTROVERSY

9. It is apparent from the face of the Complaint and the serious injuries

alleged that the amount in controversy exceeds $75,000. In the Complaint,

Plaintiffs assert claims for injuries and damages allegedly experienced by M.C.W.

as a result of prenatal exposure to Zofran®. (Compl. ¶ 11). Specifically, Plaintiffs

contend that the use of Zofran® by Plaintiff Julie Williams during her pregnancy

with M.C.W. caused M.C.W. to experience birth defects, including cleft palate. Id.

Additionally, Plaintiffs allege that M.C.W. has undergone various surgeries and

medical procedures, including a cleft palate repair, multiple myringotomies, and a

sleep study, and is expected to undergo additional orthognathic surgeries and

medical procedures in the future. (Compl. ¶¶ 11, 99). They also allege M.C.W.

“has a dysmorphic appearance of the mandible that will require further medical

attention as she grows.” (Compl. ¶¶ 11, 99). Plaintiffs further allege that they

“have suffered and incurred harm including severe and permanent pain and

suffering, mental anguish, medical expenses and other economic and noneconomic

damages, and M.C.W. will require more constant and continuous medical

monitoring and treatment than had she not been exposed to Zofran.” (Compl. ¶

103).

10. Although the Complaint does not demand a specific dollar amount in

damages, the preponderance of the evidence demonstrates that the matter in

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 4 of 9

Page 5: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

5

controversy exceeds $75,000, exclusive of interest and costs. See 28 U.S.C. §

1446(c)(2)(B) (requisite amount in controversy may be demonstrated by

“preponderance of the evidence”).

11. As the Supreme Court recently held, a removing defendant is not

required to provide evidence to support the amount in controversy in its Notice of

Removal. “[A]ll that is required is a ‘short and plain statement of the grounds for

removal,’ including ‘a plausible allegation that the amount in controversy exceeds

the jurisdictional threshold.” Dart Cherokee Basin Operating Co., LLC v. Owens,

135 S. Ct. 547, 553-54 (2014).

12. Further, in cases involving allegations of congenital defects or birth

injuries, juries nationwide have awarded plaintiffs in excess of $75,000 in

damages. See, e.g., Tobin v. Astra Pharm., Inc., No. 88-0350-L(CS), 1 Exp. Wit.

22873 (W.D. Ky. Mar. 8, 1991) (awarding $4.5 million to compensate plaintiff for

congestive heart failure and heart transplant allegedly caused by use of defendant’s

prescription medication during pregnancy); White v. Behlke, 24 Nat. J.V.R.A.7:C1,

1000 WL 177472 (Pa. Com. Pl. Nov. 17, 2008) (awarding $20.5 million in

damages for birth defects caused by defendant doctor’s malpractice); Estrada v.

Univ. of S. Fla. Bd. of Trustees, 22 Nat. J.V.R.A. 10:C3, 2007 WL 7952305 (Fla.

Cir. Ct. July 23, 2007) (awarding $23.55 million in damages as a result of a

doctor’s malpractice that resulted in plaintiff’s child being born with birth defects),

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 5 of 9

Page 6: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

6

collectively attached as Exhibit B. Indeed, numerous cases now pending against

GSK in MDL No. 2657 located in the District of Massachusetts assert nearly

identical claims as those alleged by Plaintiffs and seek damages in excess of

$75,000.2

13. Based on the nature of the alleged injuries and claims, the requested

relief, and jury verdicts and similar lawsuits from across the country, it is apparent

from the face of the Complaint that Plaintiffs seek recovery in excess of $75,000,

exclusive of interest and costs. The amount in controversy therefore exceeds the

threshold for purposes of diversity jurisdiction under 28 U.S.C. § 1332(a).

14. Accordingly, this Court has subject matter jurisdiction over this matter

pursuant to 28 U.S.C. § 1332.

2 See, e.g., Allen, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13756 (D. Mass.); Bircher, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13857 (D. Mass.); Coughlin, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13607 (D. Mass.); M. Green, et al. v. GlaxoSmithKline LLC, et al., MDL No. 1:15-cv-13821 (D. Mass.); Gruhn, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13709 (D. Mass.); Julie Hunter, et al. v. GlaxoSmithKline PLC, et al., MDL No. 1:15-cv-13569 (D. Mass.); T. Hogan, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13729 (D. Mass.); LeClair, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-10429 (D. Mass.); Mandoyan, et al. v. GlaxoSmithKline LLC, et al., MDL No. 1:15-cv-13564 (D. Mass.); Marlenee, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13585 (D. Mass.); Ragland, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13604 (D. Mass.); Regan, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13612 (D. Mass.); K. Roberts et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13710 (D. Mass.); V. Roberts, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13584 (D. Mass.); Trivisonno, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13708 (D. Mass.); and Turnage, et al. v. GlaxoSmithKline LLC, MDL No. 1:15-cv-13873 (D. Mass.).

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 6 of 9

Page 7: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

7

OTHER PROVISIONS

15. This removal is timely. GSK files this Notice of Removal within 30

days of March 14, 2016, the date of service of the summons and Complaint upon

GSK, as required by 28 U.S.C. § 1446(b).

16. The United States District Court for Northern District of Georgia,

Atlanta Division, is the federal judicial district encompassing the Superior Court of

Gwinnett County, Georgia, where this action is venued, such that this is the proper

federal district for removal of this case to federal court. 28 U.S.C. § 1441(a); 28

U.S.C. § 90(a)(2).

17. A copy of all process, pleadings, and orders that have been served

upon GSK is attached as Exhibit A to this Notice of Removal pursuant to 28

U.S.C. § 1446(a).

18. Pursuant to 28 U.S.C. § 1446(d), GSK will promptly file a copy of

this Notice of Removal with the Superior Court of Gwinnett County, Georgia, and

will serve a copy of same upon Plaintiffs.

19. By filing this Notice of Removal, GSK does not waive any

jurisdictional or other defenses that might be available to it.

20. GSK reserves the right to amend or supplement this Notice of

Removal.

WHEREFORE, Defendant GSK hereby removes this action from the

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 7 of 9

Page 8: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

8

Superior Court of Gwinnett County, Georgia, to the United States District Court

for the Northern District of Georgia, Atlanta Division, pursuant to 28 U.S.C. §§

1332, 1441, and 1446, and states that no further proceedings may be had in the

state action.

Dated: April 12, 2016

Respectfully submitted, /s/ Leonard Searcy, II

Leonard Searcy, II Georgia Bar No. 633303 SHOOK HARDY & BACON LLP 2555 Grand Blvd. Kansas City, MO 64108 Telephone: (816) 474-6550 Fax: (816) 421-5547 E-mail: [email protected]

ATTORNEYS FOR DEFENDANT

GLAXOSMITHKLINE LLC

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 8 of 9

Page 9: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

9

CERTIFICATE OF SERVICE

I hereby certify that the foregoing Notice of Removal will be sent electronically to all registered participants as identified on the Notice of Electronic Filing (“NEF”) and paper copies will be sent via first class mail to those identified as non-registered participants. /s/ Leonard Searcy, II

ATTORNEY FOR DEFENDANT

GLAXOSMITHKLINE LLC

7492490 v1

Case 1:16-cv-01175-SCJ Document 1 Filed 04/12/16 Page 9 of 9

Page 10: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 1 of 45

Page 11: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 2 of 45

Page 12: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 3 of 45

Page 13: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 4 of 45

Page 14: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 5 of 45

Page 15: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 6 of 45

Page 16: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 7 of 45

Page 17: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 8 of 45

Page 18: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 9 of 45

Page 19: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 10 of 45

Page 20: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 11 of 45

Page 21: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 12 of 45

Page 22: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 13 of 45

Page 23: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 14 of 45

Page 24: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 15 of 45

Page 25: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 16 of 45

Page 26: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 17 of 45

Page 27: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 18 of 45

Page 28: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 19 of 45

Page 29: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 20 of 45

Page 30: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 21 of 45

Page 31: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 22 of 45

Page 32: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 23 of 45

Page 33: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 24 of 45

Page 34: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 25 of 45

Page 35: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 26 of 45

Page 36: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 27 of 45

Page 37: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 28 of 45

Page 38: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 29 of 45

Page 39: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 30 of 45

Page 40: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 31 of 45

Page 41: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 32 of 45

Page 42: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 33 of 45

Page 43: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 34 of 45

Page 44: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 35 of 45

Page 45: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 36 of 45

Page 46: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 37 of 45

Page 47: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 38 of 45

Page 48: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 39 of 45

Page 49: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 40 of 45

Page 50: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 41 of 45

Page 51: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 42 of 45

Page 52: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 43 of 45

Page 53: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 44 of 45

Page 54: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Case 1:16-cv-01175-SCJ Document 1-1 Filed 04/12/16 Page 45 of 45

Page 55: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

Exhibit B

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 1 of 7

Page 56: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

� � � � �� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � ! � � � " � � � � � � # $ % & " " � � � � � � � � � � � � � � %� ' # � � % & � � ! & � ( & ! � & � � # & � # � ) * + , - . / 0 0 1 2 � 3 2 1 � 4 � 5� � � � 6 7 � � 8 � � � � $ � � � 9 # � : ; � 2 � < � � � % = � � % � � 0 ; �> ? @ A B - ? C D E F � � & # � � # G G 4 � 5 H� � I � � G � � & � � 4 � 5 H& � � � � � � � � J � $ � 7 � � $ � " # $A K > L ) F � � � � $ � " � � " � � � $ � � $ �L - M N @ B F � � � � � $ � " # O 7 � �C D A P K Q K R @ D E K S N A L K - F � � � � "Q ? A D F � � � $ � � � � � �? T ? @ Q F U : � 3 2 0 � : 2 2E A ? A D F V � � 7 $ W �) K N @ A F � � � $) ? E D E N C C ? @ B F � 7 � � � � � � $ � � � � � � � � � � � � � � � � " 7 � � � � X 7 � � � � � � � � � � � � � � " � � Y � � " � � � W � � � 7 � � � � � � � � � � I � � " � I � �? T ? @ Q Q D A ? L S E F � � � � " �) ? E D @ D E K S N A L K - F G � � � " � � � � � �) K N - E D S F � � & # � � # G G � � � � H� � � � � � � � � 7 � " � � ( # #G # ! � � & � 1 � � � � � � Z � " � � � � � � " " $& � � ! � � 1 � � � � ( � � � � � � � 7 � � � � 2 3 � � 7 � � � � " " � � V � � 7 $ W � : 2 � � �� ( � 1 4 3 2 � 5 : � [ 1 � : � 2= ' � # � 1 = = = % � ! ! # � � � & \ ! % �� G � � & � � � � � � H' " � $ W I 7 � � = � � � � � � 6 � %G # ! � � & � 1 ' " � $ W I 7 � � � � J � � Z ' 7 � $ � � � �& � � ! � � 1 [ � : = � � � � � � � � � � 2 2 2 � � 7 � � � � " " � � V � � 7 $ W � : 2 � 2 �� ( � 1 4 3 2 � 5 3 0 : 1 � [ 2 2= ' � # � 1 Y Y Y % I � I " � Y W � % $ � J

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 2 of 7

Page 57: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

� � � � �D ] > D @ A E F 9 � ! � 4 � 5 G ! � � & # � � # G G H= � " " � � � � � % ' � 7 $ � G � � W& � � ! � � 1 0 � � � � � � I ! � � � � ^ : 2 2 # � � � � � � " � � � # � � � � : [ � [ 2 � � � �� ( � 1 4 � � ; 5 � � 0 1 [ [ [ [� � # & � # � \ 1 # � � � � " � � � � $ � � � � � � � � � � � $ 7 " � � � � � � � � � � � � � � � � � � � $ 7 " � � � � � � � " � � � � � � � � � " � � � � � � � � $ � � � & � � � J 1� $ � " � � � � � " � � �& G G # � # & � # � 1 � � % 8 � $ � � ( � � � � � � " � # $ % � � � � � � � _ � � 7 � � " $ � # � � � � � � � � � � � � � � � � � $ � " � � � �` L D T K A P D @ ? ` ? L S ? a S D ) K - A D - A @ D S ? A D Q A K A P L E D ] > D @ A F = � " " � � � ' � 7 $ � G � � W

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 3 of 7

Page 58: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

b c d e f g h i j f c k l f f e m k i n o p q r s i t i u i v i m i w x y z { z | } ~ �

� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �

24 Nat. J.V.R.A. 7:C1, 1000WL 177472 (Pa.Com.Pl.) (Verdict and Settlement Summary)

Copyright (c) 2015 Jury Verdict Review Publications, Inc.Court of Common Pleas of Pennsylvania, Forty-fifth Judicial District, Lackawanna County.

WHITE vs. BEHLKE ET AL. � �� & � G 8 ! � # � � � � � � � � � H � � � � � � _ � � � � � # H � � # & � � & � � ! & � # 1 � � & \ # � � ! G ! � & � G & � & ! & � � � # � 1 � _ � # _ � �# � � � � # � G � & ' ! 1 9 \ _ � � � ! # 8 & � # � � G � � � 1 � ! � & � � � ' ! & # � � & � & _ 1 ! ' ! & �� & � � \ 1 � : 1 ( � ! & � � � � & � � & ! ! � � # ! � %E N C C ? @ B F! � � 7 " � H U � 2 � 3 2 2 � 2 2 2 8 ! � # �? A A K @ - D B F� " � � � � � � � � H 6 � � � � � � � % V � � I " � 7 � � � � � � � � V � � I " � 7 � � V � � I " � 7 Z V � � I " � 7 � 6 � W � � � Y � � & %� � � � � � � � � H � I � � � � � � $ � � � � � � � J � � � $ � " � � � 7 � H 7 � � � � % G � � � � � � = � I � � � _ � " " � � � � � � � � J � � � � � � � � " � � � � G � � � � Z � � Y I �� � $ � � � � � � & %� � � � � � � � � H � � � � � � � " H � � $ � � � " � % � � � � � � � � � � " " � � � ( � � � � � � � 7 � W � Z � � � � � � � $ � � � � � � & %6 � � _ H � � � � � $ � ! % � � � " � ! & � _ & � � � � H U 3 � 2 2 2 � 2 2 2 1 � � � � � � � � � � �� � & � H � � � � " � � � � � � � \ H � � $ W � Y � �L - M N @ L D E F� � # & � � & � � ! & � # 1 � � & \ # � � ! G ! � & � G & � & ! & � � � # � 1 � _ � # _ � � # � � � � # � G � & ' ! 1 9 \ _ � � � ! # 8 & � # � � G � � � 1 � ! � & � � � ' ! & # � � & � & _ 1 ! ' ! & � � & � � \ 1� : 1 ( � ! & � � � � & � � & ! ! � � # ! � %R ? ) A E F� � � � " � � � � � � � � " " � � � � � � � � � � � � � � � � � � � � Y � � $ � � $ " 7 � � � � � I � � � � � � $ � � � � � � � � � $ � � $ � � � � 7 � � � � � � � � � � � " � Y � � � � � � � � � � I " �� � � � � � � � � J � � � I � � � � � J � � � � 7 � � � � � � I � � � � � � � Y I � � � � � � 2 2 � % � � � � " � � � � � � � $ � � � � � � � � � � � � � � � � � � � �� I � � � � � � $ � � � � � " � � � � � � � � � � J � � J J � � � � � � � � � � � � � � � $ � � � � � � � " � � � � " � � � � � J � � � � � � � � 7 $ � " � I � � Y � � � � � � � $ � � $ � 7 � � �� � � � � � � � � � � � � � � � � � � � � � � 7 � � � � � � � � � � � � � J � � � � � � � � 7 � � � 7 � � % � � � � " � � � � � � � " � � $ " � � J � � � � � � � � � � � � � " 7 � � � � � � � " � � � �� 7 " " � � � � � � � � � � � � � $ � � � � � � � � � " � � � � � � � � J � � � $ � " $ � � � � � � % � � � � � � � � � � � � � � � � � � " � � � $ � � � J � � � � � � � � � � � � � � I � I � � �I � � � � O 7 � � � � � 7 " � � � � � � J � � � � � " J � � � � � " � � J � � � � � � � Y � � $ � Y � � I � � � � � � � � � $ � � � � " % � � � � " � � � � � � J � � � � � � � � � � � � � � � � � � � � �� � " � � � � � � � � � � � � � � � � � I � � � � � � $ � � � 6 7 � � 2 � � 2 2 � � � � � � � � � � � � � � $ � � � � � � � � � � " J � � � J � � % � � � � " � � � � � � Y � � � 7 � � �� � " � � � � � � � I � I � � 6 7 " � % � � � � " � � � � � � Y � � � � � � 7 $ � � � � � � � � � � � � � � � � � � � � � � � � � � " � � � 7 � 1� � � � � � " � I � � � � � � " � � � � � � � � � � � � � � � � � � � $ � � � � � � � Y � � � � � � � � � � � � � � � � � � � � � � � � H � 3 � % J % � � � � " � � � � � � Y � � $ � � $ � � � � � �� � � � " J � � � � � Y � � $ � � � � � " � � � � � � � � � � � � � � � $ � � � � � � � � � Y � � � I � � J � " � � � � � � � $ " 7 � � � � � $ � � � � � � � � � I � � � � � � � � I � " � � � % � � �� � � � � � � � I � � � � � � $ � � Y � � $ � � � � � � � � � � � � � � � � � � " � � � � � � � � X 7 � � � � � � � Y � � $ � " " � � I � � � � � � � � � " 7 � � � % � � � � " � � � � � �� " " � � � � � � � � � � � � � � � � � � � � � � � � � " � � 7 � � � � � � " � � � � $ � � � � $ � " � $ � J J 7 � $ � � � � � � � " � � � � � � � � $ � � � � � � � � � � � " � � � � J � W � � � J � " � 7 � � � � � � � � � � � � � � % � � � � � � � � � � � � � � � $ � � � Y � � Y � � � � � � � � � � � � � " � � � � � � � � � � � � � " � � � � � � J � � � � � � � � J � � � � � � � Y �

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 4 of 7

Page 59: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

b c d e f g h i j f c k l f f e m k i n o p q r s i t i u i v i m i w x y z { z | } ~ �

� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �

� � 7 � � � � � � � I � � � $ � " " � � � � � � � � " � � � � � � $ " � � J � � � � � � � � � � � " � � � � 7 � � � � " � � � � � � � I � � � � � � � $ � " � � � � � " � % � � � � � � � � � �I � � � � � � � $ � " � � � � � " � Y � � � � � � � � � � � � � � " � � � � � � $ " � � J � � � � � � � � � 7 � � � � � � � " � � � � � � � � � � � � � � � � � � � � � � � J � � � � � � & � I � � � � %� � � � " � � � � � � � � � � � � � � � I � � � � � � $ � � � � � � � � � � � � � � � � � � $ " � � $ � " � � � � � � � � � � � � 1 � � � $ � � � � � � � � " J � � � � � � � � � � � � I � � � � � � � $ � "� � � � � " � � � J � � � � � � � � � " � $ W � � � � � � � � � � � � � � � 7 � Y � � $ � � � X 7 � � � � � � � � � � � � � J � $ � � � � � J J � � � � � � � � � � � � � � � $ � � � %( � Y � � � � � � � � � " � � � � � � � � " " � � � � � � � � � � � � � � � � � � � � � � J � � � � � � � � � � � � � � $ � � � � � � � � � � � � � � � � $ � � � � � " � � � � " � � " � $ � � � � �� � 7 $ � " � I � � Y � � � � � J � � � � � � � � � � � � � � � $ � % � � � � " � � � � � � � " � � $ " � � J � � � � � � � � � � � � � � � � " 7 � � � � Y � � � � � " � � � � � � � � � � " � � � �� � J � � � � � � � � � � � � � � � " � � � � $ � � � � $ � " � � � � � � � � � � � � � � � � " J � � � � � � � � � � � � � � � � � � " � � � � X 7 � � � � � � � � � � � � � � � � � $ � � � � � � � � � �� � � � � 7 $ � � � � � " � I � � % � � � � " � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 7 � Y � � � 7 � � � � � � I " � � � " � � � � $ � � � � � � � � " � $ � � � � 7 � � � � � � � "J � � � � � " � � J � � � � � � � � � � � � � � � � � � J � � � � � � � � � � � � � � � � � � $ � $ � 7 � � � � � � � � � � � � � $ � � � � � � � � � � J � 7 � � � I " � � � � � � � � � � � � � $ � � � � � � � � � 7 � % � � � � � � � $ � $ � 7 � � � � � � � � � � " � � � � � � � � � � � � � � � � � $ � � � � � � � 7 � � � � � � � � � � � � � � � 7 I � � � � � 7 � � � $ $ � � � � � � �� � � � " � � � � � � � � $ " � � J � % & � J � � � � $ � � � � � � � � � � $ � � � Y � � $ � " " � � � � � � � � � J � � � " � � � 7 � � � � 1 � � " � � � 7 � � � � � � � � � � � " � � � � � � � �� � � � � � � � � � � � � � � � ; � � � � � � � � " % ' � � � � � � � J � � � � � � " � � � � � � � " " � � � � � � � � � � � I � I � � � � � " � � � � � � 7 � � � � � � � � � � � � I � � � � � J � � � � � �� � � 7 " � � � � � � " � � � � � � � � � � � � � � � � � � � % � � � I � I � � � & � _ & ! � $ � � � � Y � � �   � � � � � I � � � � � I 7 � � � Y � � � � � 7 � $ � � � � � � � � � � � � � � � � � �Y � � $ � " � � � � � � � J � 7 � � � %� � � J � � � � " � � � � � � Y � � � � � � � � � � � � " � � � � � � � � J � � � � � � � " � I 7 � Y � � � � � � J � � � � � � I � � 7 $ � � � � � � � � � � " � � � " � � � � � � 1 � � 1 � � 1J � � � 1 � " � � � � � % � � � O 7 � � � � � Y � � � ¡ � � � # � � � � � � � ¡ � � " J � � � � $ � � � � � � I � � � � � � 7 � � � � $ � � � � � � � � % ( � � � � I � � � � � � � � � �Y � � � � � � J � � � I � � � � � J � � � � � $ � � � I � � " � � " � � % � � � J � � � � " � � � � � � � � 7 � I " � � � 7 � � � � � � � J � � Y � " W � � � " W � � � � � % ( � � � � �$ � � � � " � � � � � I � � � � 7 $ � � � � � � � � $ � � � � � � � � Y � � � " $ � � � � % � � � � " � � � � � � � � � � $ � � � � � � � � � � � � � � � � � J � � � � " � � � � � � Y � " " � � � �I � � I " � � � " � � � � � � � � � � � " � � � Y � " " � � X 7 � � � � � 7 � 1 � � � 1 $ " � $ W $ � � � � � � � � � � � J � � � � � � � � � � � � J � " " � � � � � � � $ � � $ � %� � � � � � � � � � � � � � � 7 � � � � � � � � � � $ " � � $ � " � � � � � � � � � � � � � � � " J � � � � � � � � � � � � � I � � � � � � � $ � " � � � � � " � � � J � � � � � � � � � � � � " � � � � � � � �� 7 � � � $ � � � � � Y � � � � � � � � � � � J � $ � � � � � � � � � � � � � $ � � � � 7 � � � � � � � � J � � X 7 � � � � � % � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �� � � � � � � � � � � � $ � � � � � 7 $ � " � I � � � I 7 � Y � � J � � � " � 7 � � � � � � � � � � $ � � � � � $ � � � � $ � � � � � � � � � � � � � % � � � � � � � � � � � � � � 7 � � � � � � � � � � � � � � � � � � $ � � � Y � � $ � " " � � � � � � � � � � J � � � � � � � � � Y � � � � � � � % � � � � � � � � � � � � " � � � � � 7 � � � � � � � � � � � � 7 � � � � � " � � � � �� 7 � � � � � � � � � � � � � � I � � � � � J � � � � � � � � � 7 " � � � � � � � � � � " J � � � � � " � � J � � � � � � � � � � � � � � � � � � " � � � � � � J � � � � � $ � J � � � � � � �� � � � � � � " % ' � � � � � � � � � � 1 � � 1 � � � � � O 7 � � � � 7 � � � � � � � � � � � � I � � � � � � $ � � [ 2 ¢ � � " � � � � � � � � � $ � 1 � � � � � � � � � � � � � � " : 2 ¢ � � " � � � � % � � � � " � � � � � � � Y � � � � Y � � � � � U � 2 % 3 J � " " � � � � � J � � � � � � $ " 7 � � � U � J � " " � � � � � � � � " � � � � � � � � � � � � � � � � � � � � � � � �J � � � $ � " � � � � � � � 7 � � " � � � � 0 � � U � 0 % 3 J � " " � � � � � J � � � � � � � � � J � � � � " � � � � � � Y � � � � � 7 � � � � � � 0 % � � � � 1 � � � � " J � � � � �� � � $ 7 � � � � " � � � � � � %6 7 � � 8 � � � � $ � � ! � � � � Y � 7 I " � $ � � � � � � # $ %� � ' � # � ( � # � H � � � � � � " 6 7 � � 8 � � � � $ � ! � � � � Y Z & � " � � � � � 8 � " % � : � # � � 7 � ;£ ¤ ¥ ¦ § ¨ ¦ © ª « ¬ ¤ ­ ® ¯ ° ± ² ³ ´ µ ¶ · µ ¸ ¹ º » ¼ º ½ · ¾ ¿ µ À Á  à ¶ ¼ µ µ ½ Ã Ä Ã ¸  Á Å ¾ Æ ¾ Ç µ È º ½ ¸ ¶ º ¸ ¼ É µ ½ Ê · ¾

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 5 of 7

Page 60: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

f Ë e v m Ì m g h i Í q d u f v Ë d e Î Ï Ð Ë Ï Í e c Ð k Ï v d Ì m i n o o q r s i t i u i v i m i z ~ x y Ñ { o ~ ~ w �

� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �

22 Nat. J.V.R.A. 10:C3, 2007 WL 7952305 (Fla.Cir.Ct.) (Verdict and Settlement Summary)

Copyright (c) 2015 Jury Verdict Review Publications, Inc.Florida Circuit Court, Thirteenth Judicial Circuit, Hillsborough County.

ESTRADA vs. UNIVERSITY OF SOUTH FLORIDA2 [ 1 2 2 2 [ � 3� & � G 8 ! � # � � � � � � � � � H 6 7 " � � � � � 2 2 ;� � # H = ! � _ G � � ' # ! � ( 1 G & # � � ! � � # & _ � � � � # � ( 1 � � � # � # � Ò � \ � � ! � # � G # ! � � ' ! � 1� & ! � � � � _ � # _ � � � \ & � 8 # � � � ( & � � � # � # � = & � � � _ � � # 1 � � � ( # � � ' ! � = # � (� & � � # � ! � ! 1 # � & ' # � # � \ � = & � V 1 _ & � � ! # � � � � # � & � G � # � _ � � ' ! � � # ! � 1 � # G 1 � � _& � � � � & � � & ! � � � %E N C C ? @ B F! � � 7 " � H U � � � 3 3 � � 2 2 2 _ ! � � 8 ! � # �D ] > D @ A T L A - D E E D E F� " � � � � � � � � � � � � � $ � � � � � � � � � H ! � I � � � � � � � � � � � � J � � � � " � � � ! %� " � � � � � � � � � � � � � � � � � � � � � � � � � H � � � � � � $ � � I " � 7 � � � J = � � � � � " J ' � � $ � � G � %� " � � � � � � � � � � � � I � " � � � � � � � � � � � � H � � � � � G � � J � � � � J � � � J � � G � %� " � � � � � � � � � $ � � J � � � � � � � � � H � � � � � $ � � � � $ � � � � � J ' � 7 " � � � � � %� � � � � � � � � � � � � � $ � � � � � � � � � H? A A K @ - D B F� " � � � � � � � � H � � � � � � � � $ � � � 6 � � � � � � " � � � � � � � � $ � � � � � � � � $ � � � " � � ' � � � � � � Z � � � � " � � � = � � � � � " J ' � � $ � � G � %� � � � � � � � � H 6 � � $ � � � � � � " " � � 6 � � $ � � � � � � " " � � % & % � � � � � Y � � � � G � %6 � � _ H = � " " � � J � � � � �! & � _ & � � � � H U 3 � 2 2 2 � 2 2 2 1 � � � � � � � � � � �� � & � H G " � � � � � � � � \ H ( � " " � I � � � 7 � �L - M N @ L D E F= ! � _ G � � ' # ! � ( 1 G & # � � ! � � # & _ � � � � # � ( 1 � � � # � # � Ò � \ � � ! � # � G # ! � � ' ! � 1 � & ! � � �� _ � # _ � � � \ & � 8 # � � � ( & � � � # � # � = & � � � _ � � # 1 � � � ( # � � ' ! � = # � ( � & � � # � ! � ! 1 # � & ' # � # � \ � = & � V 1 _ & � � ! # � � � � # � & � G � # � _ � � ' ! � � # ! � 1 � # G 1 � � _& � � � � & � � & ! � � � %R ? ) A E F� � � � Y � � � ¡ Y � � � � 7 " I � � � � ¡ � $ � � � I � � 7 � � � I � � � � � � � � � � � � � $ � � " � I � � Y � � � � J � � � 1 � � J " � 1 � � �   � � � � � J � � � � � I � " � � � � � �� � � � � $ $ � � � � � � % � � � � " � � � � � � � $ " � � J � � � � � � � � � � � � $ � � � � J � " � � � � I � � � � � � � � � � � � � � � � � � � � � � � � � 7 � � G " � � � � � � � � " � � � � " � � � � " � � � � � � � � � � � � � � � � � � � � � � � � � � � " � � � � � � � � � � � � � I � � � � % � � � � " � � � � � � � $ � � � � � � � � � � � � � � � � � � � � � �� J � " � � � � � " � � � � " � � � � " � � � � � � � � � � � � " � � � � � � � � � � � � � � � � � � � � � � � � I � � $ � � " � � � � � � I " � J � Y � � � � � � � � � � $ � � � � 7 " � � � � � � �¡ Y � � � � 7 " I � � � � ¡ � � � � � $ � � � � Y � � � � J � � � 1

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 6 of 7

Page 61: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

f Ë e v m Ì m g h i Í q d u f v Ë d e Î Ï Ð Ë Ï Í e c Ð k Ï v d Ì m i n o o q r s i t i u i v i m i z ~ x y Ñ { o ~ ~ w �

� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �

� � J " � 1 � � �   � � � � � J � % � � � � � � � � � � � � � � 7 " � � � � � � � � " � � � $ � � � � � " � � � � � � � � � � � � � � � � � � � J � � � � � � " " � � � � � � " � � � � � �� � � � � � � � � � � � � $ � � � � � � Y � � � � � � � � � $ % � � � � � � � � � J � � � � � � � � � � � � � � � � � � � � � � $ � � Y � � � " � � � � � � � � " " � � � � � � � � I " � � � �� � � J � � � � � � � � � � � � � % � � � � � � � � � � � � � $ � � Y � � " � � � � � � � � G � I � � � � � � � � � � � � � � � � � � $ � � � � J %� � � � " � � � � � � � � � 7 � � � � � � � $ � � � � J � � � � � � � � � � � � � � � � � $ � � � � � � � J � � � � � � � � � � � � � " � � � � � � Y � � I � � Y � � � � � � J � � � � � $� � � � 7 � � � � � � � � � � � � � � 7 � � � $ � 7 " � I � � � � � � $ � " " � " � W � � % � � � � " � � � � � � � $ � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � $ �� � � � � � J � � � � � � " � � � � � � � � � � � � J � � � 1 � � J " � 1 � � �   � � � � � J � � � � � � � � " � � � � � � % � J � � � 1 � � J " � 1 � � �   � � � � � J � � � � � 7 � � � � J � " � � $ � � � � � � � � � � � $ � � � � � � � � Y � � � $ � � � � $ � � � � � � � $ � � $ " 7 � � � � � � � 7 � " � J I � � 7 � � � � � 7 � � � � � � � � � � $ � � � � � � � � � � � � �4 � � � � $ � � " � � J 5 � � � I � " � � � � � � � " W � � � � � � $ 7 " � � � J I 7 " � � � � � � � � 7 � � " � � � � W � � � � � I � J � 7 � � � � 7 � � � J � $ " 7 I � � � � � " � Y 1 � � � � � � � � � � � �� � $ � � " � � � � 7 � � � %� � � � � J � � � � � � I " � � � � � � � � � � � � � � � � � � � � � � � � � � $ � � � � � � � � � � � � � � " � � � � � � � � � � � � � � � � � " � � � � � � � � � � � I " � J � Y � � � � � � � � � � $� � � � � � � � � � � � � � � � � � � � � $ � � $ � � � � � � � � � � � � $ $ 7 � � � $ � � � � � � � � � � � � " � � � 7 " � � � � % # � � $ � � � � � � " � � � � � � � � � � � � � �� � � � � � � � � � � � � � J � � � 1 � � J " � 1 � � �   � � � � � J � � � � � � � � $ � " " � " � W � � � � � � � � " � � � � � � � � $ � 7 � " " � � � � � � 3 ¢ � � � � � I � " � � � � � � � � �� 7 � 7 � � � � � � � � � � Y � 7 " � � " � � I � I � � Y � � � � � � � � J � $ � � � � � � % � � � � " � � � � � � � � � � $ � � � � � � " � I � Y � � I � � � Y � � � � � � � � � � � �J � � � � � � � � � � � � � � � � � � � � � % ( � Y � � � � � � � � � � Y � � � � J � � � 1 � � J " � 1 � � �   � � � � � J � � � � � � " � � � � � � I � � � � � I � � � � � � � � � � � � �� 7 � � � � � � � � � � $ � � � � � � � � � � � � � % � � � � " � � � � � � J � � � � � � � � � � � � � � � � $ � � � � � " � � � � � � � � � � � � � � � � � � � � " 7 " � � � � � 7 � � � � � � �� � � � � � " � � � � � % � 7 � � � � J I � � 7 � 7 � � � � � � " � � 4 � � � " " J � � W � � � � � � J � � � 1 � � J " � 1 � � �   � � � � � J � 5 � � � � I � � � � � � 7 � � � � � � � � � � � � � 7 � Y � � � � J � " � %� � � � � $ � � � � � � " � I � Y � � � � 7 � � � � � � � " � � � � � � � " % ( � � � 7 � I " � � � Y � " W � � � � � � � � � � � 7 � � � � � � � � � � � � � � � � " � 7 I � % � " � I Y � �$ � � � � � � � � $ � 7 � � I � � � � � � � � � � � � � � � � � � � � � � � � � " % � � � � " � � � � � � � � � � � � � � � � � � � � � � � � � � � � � " � I Y � " " � � � � I � � I " � � � " � � �� � � � � � � � " � � Y � " " � � � � � � � J � " " � � � � � � � $ � � $ � � � Y � " " � � X 7 � � � � � � J � � � � � � � � � � $ � � � % � � � � " � � � � � � � " � � � � � � � 7 $ � � � ¡� � � � � � � � � � � ¡ � � " J � � � � $ � � � � " � I � � � � � " � � $ � � � � � � � � � $ " 7 � � � $ � � Y " � � � � � � � " � � � � � I � � � � � � � � � � 7 � � � � 7 I � %� � � � � � � � � � � � � 7 � � � � � � � � � � � � � � � � � $ � � � � � � � � � $ � � � � Y � � � " � � � � � � � � � I " � � � � � � � " � � � � � � � � � � � � � � � J � � � 1 � � J " � 1 � � �  � � � � � J � � � � � � " � � � � $ � � " � % � � � � � � � � � $ � � � � Y � � � � � � � � I � � � � � $ � � � � � � � " � " � � � � � $ � � � � 4 I � � � � � � " � I Y � � I � � 5� � � 7 � � � $ � � � � J � � � 1 � � J " � 1 � � �   � � � � � J � < � � � � � � � � � � � � � � " " � Y 1 7 � � � � � � 7 � � � $ � � � %� � � O 7 � � � � 7 � � � � � � � � � � � � 2 ¢ � � " � � � � � � � � � G � I � � � � � � � � � � � � � � $ � � � � " � � � � % � � � � " � � � � � � � Y � � � � Y � � � � �U � � � 3 3 � � 2 2 2 � � � J � � � � Y � � $ � Y � � � � � 7 $ � � � � � � � � Y � � � � � U � � � � � ; � ; 2 2 % � � � � Y � � � � $ " 7 � � � U 3 � � 2 2 2 � � � � � J � � � $ � "� � � � � � � < U � 0 � 3 2 2 � 2 2 2 � � 7 � 7 � � J � � � $ � " � � � � � � � < U � % 3 J � " " � � � � � � � � � " � � � � � � J � � � � � � � J � � � " � � 7 � � � < � � U � % 3 J � " " � � � � � � � � � " � � � � � � � � � � � � � � J � � � " � � 7 � � � % � � � $ � � � � � $ 7 � � � � " � � � � � � � " %6 7 � � 8 � � � � $ � � ! � � � � Y � 7 I " � $ � � � � � � # $ %� � ' � # � ( � # � H � � � � � � " 6 7 � � 8 � � � � $ � ! � � � � Y Z & � " � � � � � 8 � " % � � � # � � 7 � � 2£ ¤ ¥ ¦ § ¨ ¦ © ª « ¬ ¤ ­ ® ¯ ° ± ² ³ ´ µ ¶ · µ ¸ ¹ º » ¼ º ½ · ¾ ¿ µ À Á  à ¶ ¼ µ µ ½ Ã Ä Ã ¸  Á Å ¾ Æ ¾ Ç µ È º ½ ¸ ¶ º ¸ ¼ É µ ½ Ê · ¾

Case 1:16-cv-01175-SCJ Document 1-2 Filed 04/12/16 Page 7 of 7

Page 62: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

JS44 (Rev. 1/1 NDGA) CIVIL COVER SHEET

The JS44 civil cover sheet and the information contained herein neither replace nor supplement the filing and service of pleadings or other papers as required by law, except asprovided by local rules of court. This form is required for the use of the Clerk of Court for the purpose of initiating the civil docket record. (SEE INSTRUCTIONS ATTACHED)

I. (a) PLAINTIFF(S) DEFENDANT(S)

(b) COUNTY OF RESIDENCE OF FIRST LISTED COUNTY OF RESIDENCE OF FIRST LISTED

PLAINTIFF DEFENDANT (EXCEPT IN U.S. PLAINTIFF CASES) (IN U.S. PLAINTIFF CASES ONLY)

NOTE: IN LAND CONDEMNATION CASES, USE THE LOCATION OF THE TRACT OF LAND INVOLVED

(c) ATTORNEYS (FIRM NAME, ADDRESS, TELEPHONE NUMBER, AND ATTORNEYS (IF KNOWN)

E-MAIL ADDRESS)

II. BASIS OF JURISDICTION III. CITIZENSHIP OF PRINCIPAL PARTIES (PLACE AN “X” IN ONE BOX ONLY) (PLACE AN “X” IN ONE BOX FOR PLAINTIFF AND ONE BOX FOR DEFENDANT)

(FOR DIVERSITY CASES ONLY)

PLF DEF PLF DEF

1 U.S. GOVERNMENT 3 FEDERAL QUESTION 1 1 CITIZEN OF THIS STATE 4 4 INCORPORATED OR PRINCIPAL PLAINTIFF (U.S. GOVERNMENT NOT A PARTY) PLACE OF BUSINESS IN THIS STATE

2 U.S. GOVERNMENT 4 DIVERSITY 2 2 CITIZEN OF ANOTHER STATE 5 5 INCORPORATED AND PRINCIPAL DEFENDANT (INDICATE CITIZENSHIP OF PARTIES PLACE OF BUSINESS IN ANOTHER

IN ITEM III) STATE 3 3 CITIZEN OR SUBJECT OF A

FOREIGN COUNTRY 6 6 FOREIGN NATION

IV. ORIGIN (PLACE AN “X “IN ONE BOX ONLY)

TRANSFERRED FROM APPEAL TO DISTRICT JUDGE

1 ORIGINAL 2 REMOVED FROM 3 REMANDED FROM 4 REINSTATED OR 5 ANOTHER DISTRICT 6 MULTIDISTRICT 7 FROM MAGISTRATE JUDGE PROCEEDING STATE COURT APPELLATE COURT REOPENED (Specify District) LITIGATION JUDGMENT

V. CAUSE OF ACTION (CITE THE U.S. CIVIL STATUTE UNDER WHICH YOU ARE FILING AND WRITE A BRIEF STATEMENT OF CAUSE - DO NOT CITE

JURISDICTIONAL STATUTES UNLESS DIVERSITY)

(IF COMPLEX, CHECK REASON BELOW)

1. Unusually large number of parties. 6. Problems locating or preserving evidence

2. Unusually large number of claims or defenses. 7. Pending parallel investigations or actions by government.

3. Factual issues are exceptionally complex 8. Multiple use of experts.

4. Greater than normal volume of evidence. 9. Need for discovery outside United States boundaries.

5. Extended discovery period is needed. 10. Existence of highly technical issues and proof.

CONTINUED ON REVERSEFOR OFFICE USE ONLY

RECEIPT # AMOUNT $ APPLYING IFP MAG. JUDGE (IFP)

JUDGE MAG. JUDGE NATURE OF SUIT CAUSE OF ACTION _ (Referral)

Julie Williams and Randall Williams, Individually and as Parents and Natural Guardians of M.C.W., a Minor

GlaxoSmithKline LLC

Gwinnett County, Georgia

Robert C. BuckBuck Law Firm Suite 9401050 Crown Point Parkway Atlanta, GA 30338Telephone: (678) 338-4999

Leonard Searcy, IIShook Hardy & Bacon LLP2555 Grand Blvd. Kansas City, MO 64108Telephone: (816) 474-6550

■■

28 U.S.C. Sections 1332, 1441, and 1446.Plaintiffs allege injuries as a result of the phamaceutical product, Zofran.

■■■

New Castle, Delaware Gwinnett County, Georgia

Case 1:16-cv-01175-SCJ Document 1-3 Filed 04/12/16 Page 1 of 2

Page 63: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF …zofranlegal.com/wp-content/uploads/2016/04/Zofran-Lawsuit-Georgi… · as a result of prenatal exposure to Zofran®. (Compl. ¶

VI. NATURE OF SUIT (PLACE AN “X” IN ONE BOX ONLY)

CONTRACT - "0" MONTHS DISCOVERY TRACK150 RECOVERY OF OVERPAYMENT &

ENFORCEMENT OF JUDGMENT152 RECOVERY OF DEFAULTED STUDENT

LOANS (Excl. Veterans)153 RECOVERY OF OVERPAYMENT OF

VETERAN'S BENEFITS

CONTRACT - "4" MONTHS DISCOVERY TRACK110 INSURANCE120 MARINE130 MILLER ACT140 NEGOTIABLE INSTRUMENT151 MEDICARE ACT160 STOCKHOLDERS' SUITS190 OTHER CONTRACT195 CONTRACT PRODUCT LIABILITY196 FRANCHISE

REAL PROPERTY - "4" MONTHS DISCOVERYTRACK

210 LAND CONDEMNATION220 FORECLOSURE230 RENT LEASE & EJECTMENT240 TORTS TO LAND245 TORT PRODUCT LIABILITY290 ALL OTHER REAL PROPERTY

TORTS - PERSONAL INJURY - "4" MONTHSDISCOVERY TRACK

310 AIRPLANE315 AIRPLANE PRODUCT LIABILITY320 ASSAULT, LIBEL & SLANDER330 FEDERAL EMPLOYERS' LIABILITY340 MARINE345 MARINE PRODUCT LIABILITY350 MOTOR VEHICLE355 MOTOR VEHICLE PRODUCT LIABILITY360 OTHER PERSONAL INJURY362 PERSONAL INJURY - MEDICAL MALPRACTICE365 PERSONAL INJURY - PRODUCT LIABILITY 367 PERSONAL INJURY - HEALTH CARE/

PHARMACEUTICAL PRODUCT LIABILITY368 ASBESTOS PERSONAL INJURY PRODUCT

LIABILITY

TORTS - PERSONAL PROPERTY - "4" MONTHSDISCOVERY TRACK

370 OTHER FRAUD371 TRUTH IN LENDING380 OTHER PERSONAL PROPERTY DAMAGE 385 PROPERTY DAMAGE PRODUCT LIABILITY

BANKRUPTCY - "0" MONTHS DISCOVERY TRACK422 APPEAL 28 USC 158423 WITHDRAWAL 28 USC 157

CIVIL RIGHTS - "4" MONTHS DISCOVERY TRACK441 VOTING442 EMPLOYMENT443 HOUSING/ ACCOMMODATIONS444 WELFARE440 OTHER CIVIL RIGHTS445 AMERICANS with DISABILITIES - Employment446 AMERICANS with DISABILITIES - Other448 EDUCATION

IMMIGRATION - "0" MONTHS DISCOVERY TRACK462 NATURALIZATION APPLICATION465 OTHER IMMIGRATION ACTIONS

PRISONER PETITIONS - "0" MONTHS DISCOVERYTRACK

463 HABEAS CORPUS- Alien Detainee510 MOTIONS TO VACATE SENTENCE530 HABEAS CORPUS535 HABEAS CORPUS DEATH PENALTY540 MANDAMUS & OTHER550 CIVIL RIGHTS - Filed Pro se555 PRISON CONDITION(S) - Filed Pro se560 CIVIL DETAINEE: CONDITIONS OF

CONFINEMENT

PRISONER PETITIONS - "4" MONTHS DISCOVERYTRACK

550 CIVIL RIGHTS - Filed by Counsel555 PRISON CONDITION(S) - Filed by Counsel

FORFEITURE/PENALTY - "4" MONTHS DISCOVERYTRACK

625 DRUG RELATED SEIZURE OF PROPERTY 21 USC 881

690 OTHER

LABOR - "4" MONTHS DISCOVERY TRACK710 FAIR LABOR STANDARDS ACT720 LABOR/MGMT. RELATIONS740 RAILWAY LABOR ACT751 FAMILY and MEDICAL LEAVE ACT790 OTHER LABOR LITIGATION791 EMPL. RET. INC. SECURITY ACT

PROPERTY RIGHTS - "4" MONTHS DISCOVERY TRACK820 COPYRIGHTS840 TRADEMARK

PROPERTY RIGHTS - "8" MONTHS DISCOVERY TRACK830 PATENT

SOCIAL SECURITY - "0" MONTHS DISCOVERYTRACK

861 HIA (1395ff)862 BLACK LUNG (923)863 DIWC (405(g))863 DIWW (405(g))864 SSID TITLE XVI865 RSI (405(g))

FEDERAL TAX SUITS - "4" MONTHS DISCOVERYTRACK

870 TAXES (U.S. Plaintiff or Defendant)871 IRS - THIRD PARTY 26 USC 7609

OTHER STATUTES - "4" MONTHS DISCOVERYTRACK

375 FALSE CLAIMS ACT376 QUI TAM 31 USC 3729(a)400 STATE REAPPORTIONMENT430 BANKS AND BANKING450 COMMERCE/ICC RATES/ETC.460 DEPORTATION

470 RACKETEER INFLUENCED AND CORRUPT ORGANIZATIONS 480 CONSUMER CREDIT490 CABLE/SATELLITE TV

890 OTHER STATUTORY ACTIONS891 AGRICULTURAL ACTS893 ENVIRONMENTAL MATTERS

895 FREEDOM OF INFORMATION ACT 899 ADMINISTRATIVE PROCEDURES ACT / REVIEW OR APPEAL OF AGENCY DECISION 950 CONSTITUTIONALITY OF STATE STATUTES

OTHER STATUTES - "8" MONTHS DISCOVERY TRACK

410 ANTITRUST850 SECURITIES / COMMODITIES / EXCHANGE

OTHER STATUTES - “0" MONTHS DISCOVERY TRACK

896 ARBITRATION (Confirm / Vacate / Order / Modify)

* PLEASE NOTE DISCOVERYTRACK FOR EACH CASE TYPE.SEE LOCAL RULE 26.3

VII. REQUESTED IN COMPLAINT: CHECK IF CLASS ACTION UNDER F.R.Civ.P. 23 DEMAND $_____________________________

JURY DEMAND YES NO (CHECK YES ONLY IF DEMANDED IN COMPLAINT)

VIII. RELATED/REFILED CASE(S) IF ANY JUDGE_______________________________ DOCKET NO._______________________

CIVIL CASES ARE DEEMED RELATED IF THE PENDING CASE INVOLVES: (CHECK APPROPRIATE BOX)

1. PROPERTY INCLUDED IN AN EARLIER NUMBERED PENDING SUIT.

2. SAME ISSUE OF FACT OR ARISES OUT OF THE SAME EVENT OR TRANSACTION INCLUDED IN AN EARLIER NUMBERED PENDING SUIT.

3. VALIDITY OR INFRINGEMENT OF THE SAME PATENT, COPYRIGHT OR TRADEMARK INCLUDED IN AN EARLIER NUMBERED PENDING SUIT.

4. APPEALS ARISING OUT OF THE SAME BANKRUPTCY CASE AND ANY CASE RELATED THERETO WHICH HAVE BEEN DECIDED BY THE SAME

BANKRUPTCY JUDGE.5. REPETITIVE CASES FILED BY PRO SE LITIGANTS.

6. COMPANION OR RELATED CASE TO CASE(S) BEING SIMULTANEOUSLY FILED (INCLUDE ABBREVIATED STYLE OF OTHER CASE(S)):

7. EITHER SAME OR ALL OF THE PARTIES AND ISSUES IN THIS CASE WERE PREVIOUSLY INVOLVED IN CASE NO. , WHICH WAS

DISMISSED. This case IS IS NOT (check one box) SUBSTANTIALLY THE SAME CASE.

SIGNATURE OF ATTORNEY OF RECORD DATE

F. Dennis Saylor, IV 1:15-md-02657-FDS (D. Mass.)

4/12/16

✔■

/s/ Leonard Searcy, II

Case 1:16-cv-01175-SCJ Document 1-3 Filed 04/12/16 Page 2 of 2